Neuropsychiatric manifestations of latent toxoplasmosis on mothers and their offspring

References

• Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet 2004;363:1965–76
   PubMed Web of Science ®Google Scholar
• Robert-Gangneux F, Dardé M-L. Epidemiology of and diagnostic strategies for toxoplasmosis. Clin Microbiol Rev 2012;25:264–96
   PubMed Web of Science ®Google Scholar
• Park Y-H, Nam H-W. Clinical features and treatment of ocular toxoplasmosis. Korean J Parasitol 2013;51:393-9
   PubMed Web of Science ®Google Scholar
• Petersen E, Kijlstra A, Stanford M. Epidemiology of ocular toxoplasmosis. Ocul Immunol Inflamm 2012;20:68–75
   PubMed Web of Science ®Google Scholar
• Paquet C, Yudin M. Toxoplasmosis in pregnancy: prevention, screening, and treatment. J Obstet Gynaecol Can 2013;35:78–9
   PubMedGoogle Scholar
• Silveira C, Ferreira R, Muccioli C, et al. Toxoplasmosis transmitted to a newborn from the mother infected 20 years earlier. Am J Ophthalmol 2003;136:370–1
   PubMed Web of Science ®Google Scholar
• Kodjikian L, Hoigne I, Adam O, et al. Vertical transmission of toxoplasmosis from a chronically infected immunocompetent woman. Pediatr Infect Dis J 2004;23:272–4
   PubMed Web of Science ®Google Scholar
• Elbez-Rubinstein A, Ajzenberg D, Dardé ML, et al. Congenital toxoplasmosis and reinfection during pregnancy: case report, strain characterization, experimental model of reinfection, and review. J Infect Dis 2009;199:280–5
   PubMedGoogle Scholar
• Gavinet MF, Robert F, Firtion G, et al. Congenital toxoplasmosis due to maternal reinfection during pregnancy. J Clin Microbiol 1997;35:1276–7
   PubMed Web of Science ®Google Scholar
• Vogel N, Kirisits M, Michael E, et al. Congenital toxoplasmosis transmitted from an immunologically competent mother infected before conception. Clin Infect Dis 1996;23:1055–60
   PubMed Web of Science ®Google Scholar
• Garweg J, Scherrer J, Wallon M, et al. Reactivation of ocular toxoplasmosis during pregnancy. BJOG 2005;112:241–2
   PubMed Web of Science ®Google Scholar
• Torgerson PR, Mastroiacovo P. The global burden of congenital toxoplasmosis: a systematic review. Bull World Health Organ 2013;91:501–8
   PubMed Web of Science ®Google Scholar
• Wong W, Upton A, Thomas M. Neuropsychiatric symptoms are common in immunocompetent adult patients with Toxoplasma gondii acute lymphadenitis. Scand J Infect Dis 2012;45:357–61
   PubMedGoogle Scholar
• Habek M, Ozretić D, Žarković K, et al. Unusual cause of dementia in an immunocompetent host: toxoplasmic encephalitis. Neurol Sci 2009;30:45–9
   PubMedGoogle Scholar
• Luft BJ, Hafner R, Korzun AH, et al. Toxoplasmic encephalitis in patients with the acquired immunodeficiency syndrome. N Engl J Med 1993;329:995–1000
   PubMed Web of Science ®Google Scholar
• Dalimi A, Abdoli A. Latent toxoplasmosis and human. Iran J Parasitol 2012;7:1–17
   Web of Science ®Google Scholar
• Sullivan W Jr, Jeffers V. Mechanisms of Toxoplasma gondii persistence and latency. FEMS Microbiol Rev 2012;36:717–33
   PubMed Web of Science ®Google Scholar
• Torrey E, Bartko J, Yolken R. Toxoplasma gondii and other risk factors for schizophrenia: an update. Schizophr Bull 2012;38:642–27
   PubMed Web of Science ®Google Scholar
• Pearce B, Kruszon-Moran D, Jones JL. The relationship between Toxoplasma gondii infection and mood disorders in the third national health and nutrition survey. Biol psychiatry 2012;72:290–5
   PubMed Web of Science ®Google Scholar
• Miman O, Mutlu EA, Ozcan O, et al. Is there any role of Toxoplasma gondii in the etiology of obsessive-compulsive disorder? Psychiatry Res 2010;177:263–5
   PubMed Web of Science ®Google Scholar
• Dickerson F, Stallings C, Origoni A, et al. Antibodies to Toxoplasma gondii in individuals with mania. Bipolar Disord 2013. DOI: 10.1111/bdi.12123. [Epub ahead of print]
   Google Scholar
• Hamdani N, Daban-Huard C, Lajnef M, et al. Relationship between Toxoplasma gondii infection and bipolar disorder in a French sample. J Affect Disord 2012;148:444–8
   PubMedGoogle Scholar
• Caiaffa W, Chiari C, Figueiredo A, et al. Toxoplasmosis and mental retardation–report of a case-control study. Mem Inst Oswaldo Cruz 1993;88:253–61
   PubMedGoogle Scholar
• Palmer B. Meta-analysis of three case controlled studies and an ecological study into the link between cryptogenic epilepsy and chronic toxoplasmosis infection. Seizure 2007;16:657–63
   PubMedGoogle Scholar
• Prandota J. The importance of Toxoplasma gondii infection in diseases presenting with headaches. Headaches and aseptic meningitis may be manifestations of the Jarisch-Herxheimer reaction. Int J Neurosci 2009;119:2144–82
   PubMed Web of Science ®Google Scholar
• Koseoglu E, Yazar S, Koc I. Is Toxoplasma gondii a causal agent in migraine? Am J Med Sci 2009;338:120–2
   PubMedGoogle Scholar
• Okusaga O, Langenberg P, Sleemi A, et al. Toxoplasma gondii antibody titers and history of suicide attempts in patients with schizophrenia. Schizophr Res 2011;133:150–5
   PubMed Web of Science ®Google Scholar
• Pedersen M, Mortensen P, Norgaard-Pedersen B, Postolache T. Toxoplasma gondii infection and self-directed violence in mothers. Arch Gen psychiatry 2012;69:1123–30
   PubMed Web of Science ®Google Scholar
• Zhang Y, Träskman-Bendz L, Janelidze S, et al. Toxoplasma gondii immunoglobulin G antibodies and nonfatal suicidal self-directed violence. J Clin psychiatry 2012;73:1069–76
   PubMed Web of Science ®Google Scholar
• Prandota J. Neuropathological changes and clinical features of autism spectrum disorder participants are similar to that reported in congenital and chronic cerebral toxoplasmosis in humans and mice. Res Autism Spect Disord 2010;4:103–18
   Google Scholar
• Kusbeci O, Miman O, Yaman M, et al. Could Toxoplasma gondii have any role in Alzheimer disease? Alzheimer Dis Assoc Disord 2011;25:1–3
   PubMed Web of Science ®Google Scholar
• Miman O, Kusbeci O, Aktepe O, Cetinkaya Z. The probable relation between Toxoplasma gondii and Parkinson’s disease. Neurosci Lett 2010;475:129–31
   PubMed Web of Science ®Google Scholar
• Flegr J. Influence of latent Toxoplasma infection on human personality, physiology and morphology: pros and cons of the Toxoplasma-human model in studying the manipulation hypothesis. J Exp Biol 2013;216:127–33
   PubMed Web of Science ®Google Scholar
• Flegr J. How and why Toxoplasma makes us crazy. Trends Parasitol 2013;29:165–3
   Google Scholar
• Brown AS, Schaefer CA, Quesenberry CP Jr, et al. Maternal exposure to toxoplasmosis and risk of schizophrenia in adult offspring. Am J psychiatry 2005;162:767–73
   PubMed Web of Science ®Google Scholar
• Mortensen PB, Nørgaard-Pedersen B, Waltoft BL, et al. Toxoplasma gondii as a risk factor for early-onset schizophrenia: analysis of filter paper blood samples obtained at birth. Biol psychiatry 2007;61:688–93
   PubMed Web of Science ®Google Scholar
• Blomström A, Karlsson H, Wicks S, et al. Maternal antibodies to infectious agents and risk for non-affective psychoses in the offspring – a matched case-control study. Schizophr Res 2012;140:25–30
   PubMedGoogle Scholar
• Xiao J, Buka SL, Cannon TD, et al. Serological pattern consistent with infection with type I Toxoplasma gondii in mothers and risk of psychosis among adult offspring. Microbes Infect 2009;11:1011–18
   PubMedGoogle Scholar
• Abdoli A. Toxoplasma gondii and neuropsychiatric diseases: strain hypothesis. Neurol Sci 2013;34:1697–8
   PubMedGoogle Scholar
• Sibley LD, Khan A, Ajioka JW, Rosenthal BM. Genetic diversity of Toxoplasma gondii in animals and humans. Philos Trans R Soc Lond B Biol Sci 2009;364:2749–61
   PubMedGoogle Scholar
• Xiao J, Jones-Brando L, Talbot Jr CC, Yolken RH. Differential effects of three canonical toxoplasma strains on gene expression in human neuroepithelial cells. Infect Immun 2011;79:1363–73
   PubMedGoogle Scholar
• Saxon SA, Knight W, Reynolds DW, et al. Intellectual deficits in children born withsubclinical congenital toxoplasmosis: a preliminary report. J Pediatr 1973;82:792–7
   PubMed Web of Science ®Google Scholar
• Wilson CB, Remington JS, Stagno S, Reynolds DW. Development of adverse sequelae in children born with subclinical congenital Toxoplasma infection. Pediatrics 1980;66:767–74
   PubMed Web of Science ®Google Scholar
• Sever JL, Ellenberg JH, Ley AC, et al. Toxoplasmosis: maternal and pediatric findings in 23 000 pregnancies. Pediatrics 1988;82:181–92
   PubMed Web of Science ®Google Scholar
• Caiaffa WT, Chiari CA, Figueiredo AR, et al. Toxoplasmosis and mental retardation: report of a case-control study. Mem Inst Oswaldo Cruz 1993;88:253–61
   PubMedGoogle Scholar
• Stern H, Booth J, Elek S, Fleck D. Microbial causes of mental retardation the role of prenatal infections with cytomegalovirus, rubella virus, and Toxoplasma. Lancet 1969;294:443–8
   Google Scholar
• Noorbakhsh S, Memari F, Farhadi M, Tabatabaei A. Sensorineural hearing loss due to Toxoplasma gondii in children: a case-control study. Clin Otolaryngol 2008;33:269–73
   PubMedGoogle Scholar
• Saleh MMS, AL-Shamiri AH, Qaed AA. Seroprevalence and incidence of Toxoplasma gondii among apparently healthy and visually or hearing disabled children in taiz city, Yemen. Korean J Parasitol 2010;48:71–3
   PubMedGoogle Scholar
• de Resende LM, Andrade GQMd, Azevedo MFd, et al. Congenital toxoplasmosis: auditory and language outcomes in early diagnosed and treated children. Scientia Medica 2010;20:13–19
   Google Scholar
• Andrade GM, Resende LM, Goulart EM, et al. Hearing loss in congenital toxoplasmosis detected by newborn screening. Braz J Otorhinolaryngol 2008;74:21–8
   PubMedGoogle Scholar
• Brown E, Chau J, Atashband S, et al. A systematic review of neonatal toxoplasmosis exposure and sensorineural hearing loss. Int J Pediatr Otorhinolaryngol 2009;73:707–11
   PubMed Web of Science ®Google Scholar
• Freeman K, Oakley L, Pollak A, et al; European Multicentre Study on Congenital Toxoplasmosis. Association between congenital toxoplasmosis and preterm birth, low birthweight and small for gestational age birth. BJOG 2005;112:31–7
   PubMed Web of Science ®Google Scholar
• Kaňková Š, Flegr J. Longer pregnancy and slower fetal development in women with latent” asymptomatic” toxoplasmosis. BMC Infect Dis 2007;7:114
   PubMedGoogle Scholar
• Kaňková Š, Šulc J, Křivohlavá R, et al. Slower postnatal motor development in infants of mothers with latent toxoplasmosis during the first 18 months of life. Early Hum Dev 2012;88:879–84
   PubMedGoogle Scholar
• Carruthers V, Suzuki Y. Effects of Toxoplasma gondii infection on the brain. Schizophr Bull 2007;33:745–51
   PubMed Web of Science ®Google Scholar
• Wang T, Liu M, Gao XJ, et al. Toxoplasma gondii: the effects of infection at different stages of pregnancy on the offspring of mice. Exp Parasitol 2011;127:107–12
   PubMedGoogle Scholar
• Goodwin D, Hrubec TC, Klein BG, et al. Congenital infection of mice with Toxoplasma gondii induces minimal change in behavior and no change in neurotransmitter concentrations. J Parasitol 2012;98:706–12
   PubMedGoogle Scholar
• Prandota J. Metabolic, immune, epigenetic, endocrine and phenotypic abnormalities found in individuals with autism spectrum disorders, Down syndrome and Alzheimer’s Disease may be caused by congenital and/or acquired chronic cerebral toxoplasmosis. Res Autism Spect Disord 2011;5:14–59
   Google Scholar
• Groër MW, Yolken RH, Xiao JC, et al. Prenatal depression and anxiety in Toxoplasma gondii positive women. Am J Obstet Gynecol 2011;204:433.e1–7
   Google Scholar
• Pedersen M, Stevens H, Pedersen C, et al. Toxoplasma infection and later development of schizophrenia in mothers. Am J psychiatry 2011;168:814–21
   PubMedGoogle Scholar
• Ling V, Lester D, Mortensen P, et al. Toxoplasma gondii seropositivity and suicide rates in women. J Nerv Ment Dis 2011;199:440–4
   PubMed Web of Science ®Google Scholar
• Brown AS. Epidemiologic studies of exposure to prenatal infection and risk of schizophrenia and autism. Dev Neurobiol 2012;72:1272–6
   PubMed Web of Science ®Google Scholar
• Brown AS. Exposure to prenatal infection and risk of schizophrenia. Front Psychiatry 2011;2:63
   PubMedGoogle Scholar
• Hagberg H, Gressens P, Mallard C. Inflammation during fetal and neonatal life: implications for neurologic and neuropsychiatric disease in children and adults. Ann Neurol 2012;71:444–57
   PubMed Web of Science ®Google Scholar
• Meyer U, Feldon J, Yee BK. A review of the fetal brain cytokine imbalance hypothesis of schizophrenia. Schizophr Bull 2009;35:959–72
   PubMed Web of Science ®Google Scholar
• Meyer U, Feldon J. Prenatal exposure to infection: a primary mechanism for abnormal dopaminergic development in schizophrenia. Psychopharmacology (Berl) 2009;206:587–602
   PubMedGoogle Scholar
• Stahl W, Sekiguchi M, Kaneda Y. Multiple organ dysfunction in congenital murine toxoplasmosis. Tokai J Exp Clin Med 2004;29:53–63
   PubMedGoogle Scholar
• Stahl W, Sekiguchi M, Kaneda Y. Cerebellar anomalies in congenital murine toxoplasmosis. Parasitol Res 2002;88:507–12
   PubMedGoogle Scholar
• Hermes G, Ajioka JW, Kelly KA, et al. Neurological and behavioral abnormalities, ventricular dilatation, altered cellular functions, inflammation, and neuronal injury in brains of mice due to common, persistent, parasitic infection. J Neuroinflammation 2008;5:48
   PubMed Web of Science ®Google Scholar
• Contreras-Ochoa CO, Lagunas-Martínez A, Belkind-Gerson J, Correa D. Toxoplasma gondii invasion and replication in astrocyte primary cultures and astrocytoma cell lines: systematic review of the literature. Parasitol Res 2012;110:2089–94
   PubMed Web of Science ®Google Scholar
• Contreras-Ochoa C, Lagunas-Martínez A, Belkind-Gerson J, et al. Toxoplasma gondii invasion and replication within neonate mouse astrocytes and changes in apoptosis related molecules. Exp Parasitol 2013;134:256–65
   PubMedGoogle Scholar
• Stibbs H. Changes in brain concentrations of catecholamines and indoleamines in Toxoplasma gondii infected mice. Ann Trop Med Parasitol 1985;79:153–7
   PubMed Web of Science ®Google Scholar
• Skallová A, Kodym P, Frynta D, Flegr J. The role of dopamine in Toxoplasma-induced behavioural alterations in mice: an ethological and ethopharmacological study. Parasitology 2006;133:525–35
   PubMed Web of Science ®Google Scholar
• Xiao J, Li Y, Jones-Brando L, Yolken RH. Abnormalities of neurotransmitter and neuropeptide systems in human neuroepithelioma cells infected by three Toxoplasma strains. J Neural Transm 2013. DOI: 10.1007/s00702-013-1064-3 [Epub ahead of print]
   PubMedGoogle Scholar
• Davis K, Kahn R, Ko G, Davidson M. Dopamine in schizophrenia: a review and reconceptualization. Am J Psychiatry 1991;148:1474–86
   PubMed Web of Science ®Google Scholar
• Buttarelli F, Fanciulli A, Pellicano C, Pontieri FE. The dopaminergic system in peripheral blood lymphocytes: from physiology to pharmacology and potential applications to neuropsychiatric disorders. Curr Neuropharmacol 2011;9:278–88
   PubMed Web of Science ®Google Scholar
• Prandovszky E, Gaskell E, Martin H, et al. The neurotropic parasite Toxoplasma gondii increases dopamine metabolism. PLoS One 2011;6:e23866
   PubMed Web of Science ®Google Scholar
• Strobl JS, Goodwin DG, Rzigalinski BA, Lindsay DS. Dopamine stimulates propagation of Toxoplasma gondii tachyzoites in human fibroblast and primary neonatal rat astrocyte cell cultures. J Parasitol 2012;98:1296–9
   PubMed Web of Science ®Google Scholar
• Gaskell EA, Smith JE, Pinney JW, et al. A unique dual activity amino acid hydroxylase in Toxoplasma gondii. PLoS One 2009;4:e4801
   PubMed Web of Science ®Google Scholar
• Wegmann T, Lin H, Guilbert L, Mosmann T. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? Immunol Today 1993;14:353–6
   PubMedGoogle Scholar
• Raghupathy R. Th1-type immunity is incompatible with successful pregnancy. Immunol Today 1997;18:478–82
   PubMedGoogle Scholar
• Mor G, Cardenas I. The immune system in pregnancy: a unique complexity. Am J Reprod Immunol 2010;63:425–33
   PubMed Web of Science ®Google Scholar
• Buka SL, Tsuang MT, Torrey EF, et al. Maternal cytokine levels during pregnancy and adult psychosis. Brain Behav Immun 2001;15:411–20
   PubMed Web of Science ®Google Scholar
• Urakubo A, Jarskog LF, Lieberman JA, Gilmore JH. Prenatal exposure to maternal infection alters cytokine expression in the placenta, amniotic fluid, and fetal brain. Schizophr Res 2001;47:27–36
   PubMed Web of Science ®Google Scholar
• Patterson PH. Maternal infection: window on neuroimmune interactions in fetal brain development and mental illness. Curr Opin Neurobiol 2002;12:115–18
   PubMed Web of Science ®Google Scholar
• Miller CM, Boulter NR, Ikin RJ, Smith NC. The immunobiology of the innate response to Toxoplasma gondii. Int J Parasitol 2009;39:23–39
   PubMed Web of Science ®Google Scholar
• Menzies FM, Henriquez FL, Roberts CW. Immunological control of congenital toxoplasmosis in the murine model. Immunol Lett 2008;115:83–9
   PubMed Web of Science ®Google Scholar
• Munoz M, Liesenfeld O, Heimesaat M. Immunology of Toxoplasma gondii. Immunol Rev 2011;240:269–85
   PubMedGoogle Scholar
• Coutinho LB, Gomes AO, Araújo EC, et al. The impaired pregnancy outcome in murine congenital toxoplasmosis is associated with a pro-inflammatory immune response, but not correlated with decidual inducible nitric oxide synthase expression. Int J Parasitol 2012;42:341–52
   PubMedGoogle Scholar
• Pfaff AW, Abou-Bacar A, Letscher-Bru V, et al. Cellular and molecular physiopathology of congenital toxoplasmosis: the dual role of IFN-gamma. Parasitology 2007;134:1895–902
   PubMedGoogle Scholar
• Suzuki Y, Orellana MA, Schreiber RD, Remington JS. Interferon-gamma: the major mediator of resistance against Toxoplasma gondii. Science 1988;240:516–18
   PubMed Web of Science ®Google Scholar
• Maes M, Bosmans E, Calabrese J, et al. Interleukin-2 and interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood stabilizers. J Psychiatr Res 1995;29:141–52
   PubMed Web of Science ®Google Scholar
• Ganguli R, Yang Z, Shurin G, et al. Serum interleukin-6 concentration in schizophrenia: elevation associated with duration of illness. Psychiatry Res 1994;51:1–10
   PubMed Web of Science ®Google Scholar
• Zhang XY, Zhou DF, Zhang PY, et al. Elevated interleukin-2, interleukin-6 and interleukin-8 serum levels in neuroleptic-free schizophrenia: association with psychopathology. Schizophr Res 2002;57:247–58
   PubMed Web of Science ®Google Scholar
• Shirahata T, Muroya N, Ohta C, et al. Correlation between increased susceptibility to primary Toxoplasma gondii infection and depressed production of gamma interferon in pregnant mice. Microbiol Immunol 1992;36:81–91
   PubMedGoogle Scholar
• Shirahata T, Muroya N, Ohta C, et al. Enhancement by recombinant human interleukin 2 of host resistance to Toxoplasma gondii infection in pregnant mice. Microbiol Immunol 1993;37:583–90
   PubMedGoogle Scholar
• Shiono Y, Mun HS, He N, et al. Maternal–fetal transmission of Toxoplasma gondii in interferon-γ deficient pregnant mice. Parasitol Int 2007;56:141–8
   PubMedGoogle Scholar
• Jebbari H, Roberts C, Ferguson D, et al. A protective role for IL-6 during early infection with Toxoplasma gondii. Parasite Immunol 1998;20:231–40
   PubMed Web of Science ®Google Scholar
• Villegas EN, Lieberman LA, Carding SR, Hunter CA. Susceptibility of interleukin-2-deficient mice to Toxoplasma gondii is associated with a defect in the production of gamma interferon. Infect Immun 2002;70:4757–61
   PubMedGoogle Scholar
• Lahmar I, Abou-Bacar A, Abdelrahman T, et al. Cytokine profiles in toxoplasmic and viral uveitis. J Infect Dis 2009;199:1239–49
   PubMed Web of Science ®Google Scholar
• Fischer HG, Nitzgen B, Reichmann G, Hadding U. Cytokine responses induced by Toxoplasma gondii in astrocytes and microglial cells. Eur J Immunol 1997;27:1539–48
   PubMedGoogle Scholar
• Müller N, Riedel M, Ackenheil M, Schwarz MJ. Cellular and humoral immune system in schizophrenia: a conceptual re-evaluation. World J Biol Psychiatry 2000;1:173–9
   PubMedGoogle Scholar
• Hama T, Kushima Y, Miyamoto M, et al. Interleukin-6 improves the survival of mesencephalic catecholaminergic and septal cholinergic neurons from postnatal, two-week-old rats in cultures. Neuroscience 1991;40:445–52
   PubMed Web of Science ®Google Scholar
• Rostami Nejad M, Jahani Sherafat S, Roshani M, et al. The evaluation of interleukin-8 chemokine in chronic and acute Toxoplasma gondii infection. Gastroenterol Hepatol Bed Bench 2010;4:34–7
   Google Scholar
• Brown AS, Hooton J, Schaefer CA, et al. Elevated maternal interleukin-8 levels and risk of schizophrenia in adult offspring. Am J Psychiatry 2004;161:889–95
   PubMed Web of Science ®Google Scholar